Inhibition of PI3K/Akt/mTOR signaling by curcumin: a novel approach to mitigate synovial fibrosis in knee osteoarthritis
The Korean Journal of Physiology & Pharmacology · 01.07.2026 · 30 (4) · 327-337
DOI: 10.4196/kjpp.25.289 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Korean Journal of Physiology & Pharmacology, online erschienen am 16.03.2026. Verfasst von Chenglong He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Traumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Youth Science Fund Project, Jiangsu Provincial Hospital of Chinese Medicine.
Abstract (Originalsprache)
Curcumin (CUR) is used in treating knee osteoarthritis (KOA), but its effects on synovial fibrosis and underlying mechanisms remain unclear. In vivo, a rat KOA model was established via anterior cruciate ligament transection (ACLT), followed by CUR administration. Synovial fibrosis, autophagy, and PI3K/AKT/mTOR pathway were assessed. In vitro, TGF-β1-induced fibroblast-like synoviocytes (FLSs) were treated with CUR. Fibrosis markers, autophagy activity, and PI3K/AKT/mTOR pathway proteins were analyzed. CUR alleviated synovial fibrosis in ACLT-induced rats. In FLSs, CUR reduced TGF-β1-stimulated fibrosis, suppressed PI3K/Akt/mTOR signaling, and enhanced autophagy. In vivo results confirmed CUR inhibited PI3K/Akt/mTOR and activated autophagy. CUR attenuated synovial fibrosis by activating protective autophagy via inhibition of the PI3K/Akt/mTOR pathway, elucidating a novel anti-fibrotic mechanism for KOA therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics and Traumatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu 210029, P. R. China.
- First College of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P. R. China.
- Key Laboratory for Metabolic Diseases in Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P. R. China.
- Department of Orthopedics and Traumatology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210017, P. R. China.
Förderung
- National Natural Science Foundation of China
- Youth Science Fund Project
- Jiangsu Provincial Hospital of Chinese Medicine
- Jiangsu Provincial Hospital of Traditional Chinese Medicine Clinical Medical Innovation Center for Knee Osteoarthritis
- Jiangsu Provincial Medical Key Discipline (Laboratory) Cultivation Unit
- Nanjing University of Chinese Medicine
Zitieren
APA
He, C., Shi, L., Zhang, L., Jiang, R., Liu, D., Liao, T., Wu, P., & Mao, J. (2026). Inhibition of PI3K/Akt/mTOR signaling by curcumin: a novel approach to mitigate synovial fibrosis in knee osteoarthritis. The Korean Journal of Physiology & Pharmacology, 30(4), 327-337. https://doi.org/10.4196/kjpp.25.289
Vancouver
He C, Shi L, Zhang L, Jiang R, Liu D, Liao T, et al. Inhibition of PI3K/Akt/mTOR signaling by curcumin: a novel approach to mitigate synovial fibrosis in knee osteoarthritis. The Korean Journal of Physiology & Pharmacology. 2026;30(4):327-337. doi:10.4196/kjpp.25.289
BibTeX
@article{He2026,
author = {He, Chenglong and Shi, Lei and Zhang, Licheng and Jiang, Rui and Liu, Deren and Liao, Taiyang and Wu, Peng and Mao, Jun},
title = {Inhibition of PI3K/Akt/mTOR signaling by curcumin: a novel approach to mitigate synovial fibrosis in knee osteoarthritis},
journal = {The Korean Journal of Physiology & Pharmacology},
year = {2026},
volume = {30},
number = {4},
pages = {327--337},
doi = {10.4196/kjpp.25.289}
}
EUVIMED